New Quillichew ER is the first chewable option for ADHD

Roni Shye
Roni Shye, PharmD BCGP BCACP, is a licensed pharmacist in the states of Florida, Ohio, and Pennsylvania.
Posted on

ADHD (attention deficit hyperactivity disorder) affects around 11% of children ages 4 to 17 years of age, according to the CDC (Centers for Disease Control and Prevention)—and that number continues to rise.

New Quillichew ER (methylphenidate) may offer an easier way to take ADHD medication, for children or anyone who prefers not to swallow a pill. It was approved in December 2015, and is now available in pharmacies.

What is Quillichew ER used for?
Quillichew ER chewable tablets are used to treat ADHD.

Is there anything unique about Quillichew ER?

Yes. Quillichew ER is the first FDA approved extended-release chewable ADHD medication for children 6 and older.

How is Quillichew ER used?

Your or your child’s dose will be individualized, and determined by your doctor.

However, the recommended starting dose is 20mg, chewed and swallowed once daily in the morning.

The maximum recommended daily dose of Quillichew ER is 60mg.

How is Quillichew ER available?
Quillichew ER comes as a chewable tablet in 20 mg, 30 mg, and 40 mg strengths. The 20 mg and 30 mg are scored, meaning they may be safely split, while the 40 mg is not.

When will Quillichew ER be available?
Quillichew ER is in pharmacies now.

Is there anything else I should know?

Like other ADHD medications, Quillichew ER is considered a schedule II controlled substance by the DEA. This means that you’ll need a written prescription from your doctor for each fill, and you can’t get a refill without a new prescription, among other restrictions.

Want more information?

See the press release from the manufacturer, Pfizer, here.

Drugs featured in this story

Filed under